Clinical and economic burden of bacteremia due to multidrug-resistant organisms in Korea: a prospective case control study

Immunology and Microbiology

• Carbapenem Resistant Enterobacteriaceae 100%
• Methicillin-Resistant Staphylococcus Aureus 100%
• Vancomycin-Resistant Enterococcus 100%
• Pseudomonas aeruginosa 100%
• Acinetobacter Baumannii 100%
• Mortality Rate 50%

Medicine and Dentistry

• Case-Control Study 100%
• Bloodstream Infection 100%
• Infection 50%
• Health Care Cost 50%
• Methicillin Resistant Staphylococcus Aureus 33%
• Acinetobacter Baumannii 33%
• Pseudomonas aeruginosa 33%
• Vancomycin Resistant Enterococcus 33%
• Carbapenem-Resistant Enterobacteriaceae 33%
• Mortality Rate 16%
• Infection Control 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Case-Control Study 100%
• Bloodstream Infection 100%
• Infection 66%
• Methicillin-Resistant Staphylococcus Aureus 33%
• Pseudomonas aeruginosa 33%
• Vancomycin-Resistant Enterococcus 33%
• Carbapenem Resistant Enterobacteriaceae 33%
• Acinetobacter Baumannii 33%
• Mortality Rate 16%